相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Protein Kinase A-regulated Assembly of a MEF2.HDAC4 Repressor Complex Controls c-Jun Expression in Vascular Smooth Muscle Cells
Joseph W. Gordon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
GIT1 mediates HDAC5 activation by angiotensin II in vascular smooth muscle cells
Jinjiang Pang et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
CaMKII-δ isoform regulation of neointima formation after vascular injury
Suzanne J. House et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Role of Ca2+/calmodulin-dependent protein kinase II in development of vascular dysfunction in diabetic rats with hypertension
Mariam H. M. Yousif et al.
CELL BIOCHEMISTRY AND FUNCTION (2008)
Histone deacetylase 5 acquires calcium/calmodulin-dependent kinase II responsiveness by oligomerization with histone deacetylase 4
Johannes Backs et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Angiotensin II stimulates protein kinase D-dependent histone deacetylase 5 phosphorylation and nuclear export leading to vascular smooth muscle cell hypertrophy
Xiangbin Xu et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Calcium/calmodulin-dependent protein kinase II-δ isoform regulation of vascular smooth muscle cell proliferation
Suzanne J. House et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
CaM kinase II selectively signals to histone deacetylase 4 during cardiornyocyte hypertrophy
Johannes Backs et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
KN-93 (2-[N-(2-hydroxyethyl)]-N-(4-methoxybenzenesulfonyl)]amino-N-( 4-chlorocinnamyl)-N-methylbenzylamine), a calcium/calmodulin-dependent protein kinase II inhibitor, is a direct extracellular blocker of voltage-gated potassium channels
S Rezazadeh et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Control of cardiac growth by histone acetylation/deacetylation
J Backs et al.
CIRCULATION RESEARCH (2006)
Calmodulin kinase II inhibition protects against structural heart disease
R Zhang et al.
NATURE MEDICINE (2005)
Cyclin-dependent kinase inhibitor, p21Waf1, regulates vascular smooth muscle cell hypertrophy
K Okamoto et al.
HYPERTENSION RESEARCH (2004)
Myocyte enhancer factor 2 mediates vascular inflammation via the p38-dependent pathway
E Suzuki et al.
CIRCULATION RESEARCH (2004)
A role for PYK2 in ANG II-dependent regulation of the PHAS-1-eIF4E complex by multiple signaling cascades in vascular smooth muscle
P Rocic et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2003)
Angiotensin II induces myocyte enhancer factor 2-and calcineurin/nuclear factor of activated T cell-dependent transcriptional activation in vascular myocytes
E Suzuki et al.
CIRCULATION RESEARCH (2002)
Functional significance of activation of calcium/calmodulin-dependent protein kinase II in angiotensin II-induced vascular hyperplasia and hypertension
MM Muthalif et al.
HYPERTENSION (2002)
Ca2+-calmodulin-dependent protein kinase II-dependent activation of contractility in ferret aorta
I Kim et al.
JOURNAL OF PHYSIOLOGY-LONDON (2000)
A simple method for the rapid generation of recombinant adenovirus vectors
RD Anderson et al.
GENE THERAPY (2000)
分享论文
